Paper25004875
Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy.
Chen HM and 6 others. Am J Chin Med, 2014. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy. Papers, record 25004875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25004875
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Cardiomegaly | Major topic |
| Flavanones | Major topic |
| HMGB1 Protein | Major topic |
| Lipopolysaccharides | Major topic |
| Matrix Metalloproteinase 2 | Major topic |
| Matrix Metalloproteinase 9 | Major topic |
| Phytotherapy | Major topic |
| Animals | |
| Cells, Cultured | |
| Down-Regulation | |
| Myocytes, Cardiac | |
| Nitric Oxide Synthase Type II | |
| Protein Biosynthesis | |
| Rats, Wistar | |
| Reactive Oxygen Species | |
| Scutellaria baicalensis |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42170474 | Synergistic combination of taxifolin and baicalein protects against alloxan-induced diabetic cardiomyopathy by mitigating oxidative stress through the Nrf2/HO-1 signaling pathway. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42170474 | PubMed |
| 41574690 | Natural products as multi‑target therapies for sepsis‑induced myocardial dysfunction (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41574690 | PubMed |
| 40205009 | Wogonin attenuates septic cardiomyopathy by suppressing ALOX15-mediated ferroptosis. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40205009 | PubMed |
| 35870110 | Protective and therapeutic effects of Scutellaria baicalensis and its main active ingredients baicalin and baicalein against natural toxicities and physical hazards: a review of mechanisms. | Daru | 2022 | https://conductscience.org/library/papers/35870110 | PubMed |
| 35720285 | High Mobility Group Proteins in Sepsis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720285 | PubMed |
| 34681737 | Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681737 | PubMed |
| 33668293 | Divergent and Overlapping Roles for Selected Phytochemicals in the Regulation of Pathological Cardiac Hypertrophy. | Molecules | 2021 | https://conductscience.org/library/papers/33668293 | PubMed |
| 33398367 | Propofol ameliorates endotoxin‑induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARγ/HMGB1/NLRP3 axis. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33398367 | PubMed |
| 32796955 | Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. | Acta Pharmacol Sin | 2021 | https://conductscience.org/library/papers/32796955 | PubMed |
| 32629817 | Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32629817 | PubMed |
| 32209725 | Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32209725 | PubMed |
| 31880404 | Baicalein inhibits mitochondrial apoptosis induced by oxidative stress in cardiomyocytes by stabilizing MARCH5 expression. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/31880404 | PubMed |
| 30249874 | Deglycosylation of wogonoside enhances its anticancer potential. | J Cancer Res Ther | 2018 | https://conductscience.org/library/papers/30249874 | PubMed |
| 29765498 | Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29765498 | PubMed |
| 28348451 | Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. | Dis Markers | 2017 | https://conductscience.org/library/papers/28348451 | PubMed |
| 27355349 | HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload. | PLoS One | 2016 | https://conductscience.org/library/papers/27355349 | PubMed |
| 26398706 | Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin. | Int J Oncol | 2015 | https://conductscience.org/library/papers/26398706 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25004875
GET https://conductscience.org/api/papers/v1/25004875/authors